Breakthrough innovative Technology, CardioSen’C™, the first personal cellular-digital 12-lead ECG transmitter. The CardioSen’C™ transmits a patient’s complete 12-lead ECG and rhythm read-out strip in real-time to support professional evaluation of medical conditions such as arrhythmia, ischemia, and myocardial infarction. The CardioSen’C™ is a cellular-digital 12-lead ECG transmitter device for personal use, which reliably transmits a patient’s 12-lead ECG, directly to SHL’s medical monitoring center, for remote and real-time evaluation of arrhythmia, ischemia, and myocardial infarction conditions. The received ECG is analyzed by SHL’s on-call medical professional team. Together with the clinical description, provided by the in distress person, the medical team possesses the necessary data to evaluate the situation and provide medical assistance if necessary. SHL’s advanced Telemedicine service can help to drastically reduce morbidity and mortality rates following an acute myocardial infarction or other severe cardiac incidents.